Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh T Packiam

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Urology Practice|May 5, 2023
Editorial CommentaryVignesh T Packiam
Translational Andrology and Urology|January 18, 2021
Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival?Vignesh T Packiam
Journal of Clinical Medicine|July 27, 2024
Contemporary Treatment of NMIBC-Is It Time to Move on from BCG?Rachel Passarelli, Vignesh T Packiam
European Urology|September 27, 2020
Are We Moving Closer to Accurate Restaging after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer?Vignesh T Packiam, Bimal Bhindi
Translational Andrology and Urology|April 13, 2018
Ongoing efforts to reduce perioperative morbidity of radical cystectomy: towards widespread adoption of extended-duration thromboprophylaxisVignesh T Packiam, Joseph J Pariser
Translational Andrology and Urology|August 9, 2019
Association between perioperative morbidity and mortality after radical cystectomy: an opportunity to understand the complication snowball effectVignesh T Packiam, Joseph J Pariser
Annals of Translational Medicine|February 5, 2020
The limits of complex partial nephrectomy: are there any?Vignesh T Packiam, R Houston Thompson
Evidence-Based Medicine|November 12, 2017
Minimal difference in survival between radical prostatectomy and observation in men with modest life expectancyVignesh T Packiam, Scott E Eggener
The Journal of Urology|February 25, 2025
Editorial CommentMelinda Z Fu, Vignesh T Packiam
The Journal of Urology|September 10, 2024
Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialRachel Passarelli, Saum Ghodoussipour, Vignesh T Packiam
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Urology Practice|May 5, 2023
Editorial CommentaryVignesh T Packiam
Translational Andrology and Urology|January 18, 2021
Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival?Vignesh T Packiam
Journal of Clinical Medicine|July 27, 2024
Contemporary Treatment of NMIBC-Is It Time to Move on from BCG?Rachel Passarelli, Vignesh T Packiam
European Urology|September 27, 2020
Are We Moving Closer to Accurate Restaging after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer?Vignesh T Packiam, Bimal Bhindi
Translational Andrology and Urology|April 13, 2018
Ongoing efforts to reduce perioperative morbidity of radical cystectomy: towards widespread adoption of extended-duration thromboprophylaxisVignesh T Packiam, Joseph J Pariser
Translational Andrology and Urology|August 9, 2019
Association between perioperative morbidity and mortality after radical cystectomy: an opportunity to understand the complication snowball effectVignesh T Packiam, Joseph J Pariser
Annals of Translational Medicine|February 5, 2020
The limits of complex partial nephrectomy: are there any?Vignesh T Packiam, R Houston Thompson
Evidence-Based Medicine|November 12, 2017
Minimal difference in survival between radical prostatectomy and observation in men with modest life expectancyVignesh T Packiam, Scott E Eggener
The Journal of Urology|February 25, 2025
Editorial CommentMelinda Z Fu, Vignesh T Packiam
The Journal of Urology|September 10, 2024
Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialRachel Passarelli, Saum Ghodoussipour, Vignesh T Packiam
Pageof 14